MicroRNA Expression Analysis: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction

PLoS ONE - United States
doi 10.1371/journal.pone.0014736
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

MicroRNAs in Myocardial Infarction

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2013English

Trial of Propranolol in Acute Myocardial Infarction.

BMJ
1968English

The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

MicroRNAs in Pathophysiology of Acute Myocardial Infarction and Cardiogenic Shock

Bratislava Medical Journal
2018English

Constructing Differential Co‑expression Network to Predict Key Pathways for Myocardial Infarction

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Long Term Propranolol Treatment and Changes in Body Weight After Myocardial Infarction.

BMJ
1990English

Circulating MicroRNAs Are Promising Novel Biomarkers of Acute Myocardial Infarction

Internal Medicine
Internal MedicineMedicine
2011English

MicroRNAs (miRNAs) Based Biomarkers for Acute Myocardial Infarction(AMI) Diagnosis

Journal of Clinical & Experimental Cardiology
2012English

MicroRNA-331 and microRNA-151-3p as Biomarkers in Patients With ST-segment Elevation Myocardial Infarction

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy